SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group ($CAR) is experiencing a massive, sentiment-driven short squeeze that has pushed the stock to record highs, fueled by high concentration of float ownership by a few major hedge funds. While retail investors are aggressively debating the sustainability of this parabolic move, many community members are highlighting the potential for a swift and severe reversal as the company holds significant debt and has authorized the sale of additional shares.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending following a double beat on Q1 earnings, with investors cheering narrowing losses and robust production rates despite ongoing cash flow challenges. The community is focused on the massive order backlog and the potential for long-term recovery, though some traders remain cautious about the impact of delivery constraints and wider market volatility.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying significantly as investors respond to an exclusive interview where the CFO reaffirmed a production order linked to Marvell and hinted at further purchase orders from hyperscalers. Community sentiment is overwhelmingly bullish, with active discussions focusing on a potential short squeeze, the company's progress from R&D to commercial execution, and the defensive posture taken by management against short-seller reports.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. The firm also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment includes products and services sold for applications within the data center, communication networks and commercial and industrial markets in North America and Latin America. The Asia Pacific segment consists of products and services sold for applications within the data center, communication networks and commercial and industrial markets throughout Greater China, Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Westerville, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings is trending as investors weigh its robust Q1 earnings beat and raised full-year guidance against a softer-than-expected near-term outlook that triggered a brief sell-off. The community remains divided between those viewing the pullback as a prime 'buy-the-dip' opportunity driven by sustained AI infrastructure demand and those concerned by high valuation multiples.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is surging on news of a proposed special auction for new power capacity, which is fueling significant market excitement about its role as a key supplier of turbines and infrastructure for AI data centers. While the community is actively debating the potential for a stock split and long-term valuation, sentiment remains bullish as investors view the company as a primary beneficiary of the massive, decade-long energy buildout.

Robinhood Ventures Fund I invest in companies located in the United States. The fund focuses on a broad range of sectors and industries. It provides financing for early stage transactions.

Robinhood Ventures Fund I - Common shares of beneficial interest

Robinhood Ventures Fund is trending as retail investors react to the firm's recent move to include major private technology companies, such as OpenAI, within its portfolio. The community is actively discussing the fund's potential to provide broader exposure to high-growth private assets while debating the strategic implications of its current valuations and long-term investment horizon.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T is seeing strong investor interest as the community highlights consistent execution, a robust dividend, and the stock's role as a defensive play during market volatility. Shareholders are actively discussing the company's long-term infrastructure investment plans and its strategic position in the evolving AI and data connectivity landscape.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is surging following positive registrational trial data for its CAR-T therapy, miv-cel, in Stiff Person Syndrome, with investors particularly focused on the therapy's high efficacy and potential to be a first-in-class treatment. The community is actively discussing the stock's significant long-term potential in the autoimmune space, debating the risk of dilution versus the likelihood of a strategic partnership or buyout.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is experiencing significant volatility and retail speculation as investors debate its valuation relative to its AI infrastructure role and high price-to-sales ratio. While bulls point to strategic partnerships in next-gen data centers and potential short-squeeze dynamics, skeptics are actively highlighting the stock's recent price surge, institutional short positions, and upcoming earnings as potential catalysts for a pullback.

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.

Inhibrx Biosciences Inc.

Inhibrx Inc

Inhibrx is trending due to robust clinical data for ozekibart in treating rare cancers, which has sparked significant interest from major pharmaceutical players for a potential high-value asset sale. Investors and community members are actively discussing the stock's transition from a clinical-stage entity to a potential buyout candidate, while debating the long-term valuation of its remaining pipeline and the potential for a share dilution to support future commercialization.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$INSG Good time to sell Covered Calls again! Shoot for $16 or $17+ calls that expire in a month. I just sold $16 Calls with May expiry.

Their next earnings will likely be by mid May. So ensure your calls expire before that to pocket your premium. As I am sure the ER will be good and there will be a pop in the stock price with new higher support levels, don&#39;t want to sell your shares too early.

After next ER you can again sell your calls for $20 prices. Rinse and Repeat

arnulfo de bartolome

StockTwits For Android 

Inseego Corp

 Good time to sell Covered Calls again! Shoot for $16 or $17+ calls that expire in a month. I just sold $16 Calls with May expiry.

Their next earnings will likely be by mid May. So ensure your calls expire before that to pocket your premium. As I am sure the ER will be good and there will be a pop in the stock price with new higher support levels, don't want to sell your shares too early.

After next ER you can again sell your calls for $20 prices. Rinse and Repeat